Previous studies have found that pathogenic variants in MBTPS2 and SREBP1 underlie IFAP syndrome by affecting cholesterol homeostasis and epidermal/epithelial cholesterol metabolism (Mégarbané & Mégarbané, 2011; Wang et al, 2020). This evidence concerns the gene SREBF1 and IFAP syndrome.